Literature DB >> 20675163

Enzymatic activity of methionine adenosyltransferase variants identified in patients with persistent hypermethioninemia.

Joaquín Fernández-Irigoyen1, Enrique Santamaría, Yin-Hsiu Chien, Wuh-Liang Hwu, Stanley H Korman, Hanna Faghfoury, Andreas Schulze, George E Hoganson, Sally P Stabler, Robert H Allen, Conrad Wagner, S Harvey Mudd, Fernando J Corrales.   

Abstract

Methionine adenosyltransferases (MAT's) are central enzymes in living organisms that have been conserved with a high degree of homology among species. In the liver, MAT I and III, tetrameric and dimeric isoforms of the same catalytic subunit encoded by the gene MAT1A, account for the predominant portion of total body synthesis of S-adenosylmethionine (SAM), a versatile sulfonium ion-containing molecule involved in a variety of vital metabolic reactions and in the control of hepatocyte proliferation and differentiation. During the past 15years 28 MAT1A mutations have been described in patients with elevated plasma methionines, total homocysteines at most only moderately elevated, and normal levels of tyrosine and other aminoacids. In this study we describe functional analyses that determine the MAT and tripolyphosphatase (PPPase) activities of 18 MAT1A variants, six of them novel, and none of them previously assayed for activity. With the exception of G69S and Y92H, all recombinant proteins showed impairment (usually severe) of MAT activity. Tripolyphosphate (PPPi) hydrolysis was decreased only in some mutant proteins but, when it was decreased MAT activity was always also impaired.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675163     DOI: 10.1016/j.ymgme.2010.07.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

1.  Thirteen Patients with MAT1A Mutations Detected Through Newborn Screening: 13 Years' Experience.

Authors:  S Chadwick; K Fitzgerald; B Weiss; C Ficicioglu
Journal:  JIMD Rep       Date:  2014-01-21

2.  MAT2A mutations predispose individuals to thoracic aortic aneurysms.

Authors:  Dong-chuan Guo; Limin Gong; Ellen S Regalado; Regie L Santos-Cortez; Ren Zhao; Bo Cai; Sudha Veeraraghavan; Siddharth K Prakash; Ralph J Johnson; Ann Muilenburg; Marcia Willing; Guillaume Jondeau; Catherine Boileau; Hariyadarshi Pannu; Rocio Moran; Julie Debacker; Michael J Bamshad; Jay Shendure; Deborah A Nickerson; Suzanne M Leal; C S Raman; Eric C Swindell; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2014-12-31       Impact factor: 11.025

3.  Methionine and methionine sulfoxide treatment induces M1/classical macrophage polarization and modulates oxidative stress and purinergic signaling parameters.

Authors:  Lien M Dos Santos; Tatiane M da Silva; Juliana H Azambuja; Priscila T Ramos; Pathise S Oliveira; Elita F da Silveira; Nathalia S Pedra; Kennia Galdino; Carlus A T do Couto; Mayara S P Soares; Rejane G Tavares; Roselia M Spanevello; Francieli M Stefanello; Elizandra Braganhol
Journal:  Mol Cell Biochem       Date:  2016-10-17       Impact factor: 3.396

4.  Methionine Adenosyltransferase Engineering to Enable Bioorthogonal Platforms for AdoMet-Utilizing Enzymes.

Authors:  Tyler D Huber; Jonathan A Clinger; Yang Liu; Weijun Xu; Mitchell D Miller; George N Phillips; Jon S Thorson
Journal:  ACS Chem Biol       Date:  2020-03-03       Impact factor: 5.100

5.  Determination of Autosomal Dominant or Recessive Methionine Adenosyltransferase I/III Deficiencies Based on Clinical and Molecular Studies.

Authors:  Yoo-Mi Kim; Ja Hye Kim; Jin Choi; Kim Gu-Hwan; Jae-Min Kim; Minji Kang; In-Hee Choi; Chong Kun Cheon; Young Bae Sohn; Marco Maccarana; Han-Wook Yoo; Beom Hee Lee
Journal:  Mol Med       Date:  2016-02-18       Impact factor: 6.354

Review 6.  S-adenosylmethionine metabolism and liver disease.

Authors:  José M Mato; M Luz Martínez-Chantar; Shelly C Lu
Journal:  Ann Hepatol       Date:  2013 Mar-Apr       Impact factor: 2.400

7.  Confirmation that MAT1A p.Ala259Val mutation causes autosomal dominant hypermethioninemia.

Authors:  Michael J Muriello; Sarah Viall; Teodoro Bottiglieri; Kristina Cusmano-Ozog; Carlos R Ferreira
Journal:  Mol Genet Metab Rep       Date:  2017-07-15

8.  Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations.

Authors:  Marwan Nashabat; Sultan Al-Khenaizan; Majid Alfadhel
Journal:  Ther Clin Risk Manag       Date:  2018-02-02       Impact factor: 2.423

Review 9.  Mudd's disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes.

Authors:  Yin-Hsiu Chien; Jose E Abdenur; Federico Baronio; Allison Anne Bannick; Fernando Corrales; Maria Couce; Markus G Donner; Can Ficicioglu; Cynthia Freehauf; Deborah Frithiof; Garrett Gotway; Koichi Hirabayashi; Floris Hofstede; George Hoganson; Wuh-Liang Hwu; Philip James; Sook Kim; Stanley H Korman; Robin Lachmann; Harvey Levy; Martin Lindner; Lilia Lykopoulou; Ertan Mayatepek; Ania Muntau; Yoshiyuki Okano; Kimiyo Raymond; Estela Rubio-Gozalbo; Sabine Scholl-Bürgi; Andreas Schulze; Rani Singh; Sally Stabler; Mary Stuy; Janet Thomas; Conrad Wagner; William G Wilson; Saskia Wortmann; Shigenori Yamamoto; Maryland Pao; Henk J Blom
Journal:  Orphanet J Rare Dis       Date:  2015-08-20       Impact factor: 4.123

Review 10.  Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders.

Authors:  Ivo Barić; Christian Staufner; Persephone Augoustides-Savvopoulou; Yin-Hsiu Chien; Dries Dobbelaere; Sarah C Grünert; Thomas Opladen; Danijela Petković Ramadža; Bojana Rakić; Anna Wedell; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2016-09-26       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.